Advertisement

HIV und Aids pp 126-154 | Cite as

Die kindliche HIV-Infektion

  • K. Seel
  • C. Feiterna-Sperling
  • I. Grosch-Wörner

Zusammenfassung

Neben der Übertragung der HIV-Infektion durch infektiöses Blut oder Blutprodukte oder sexuellen Kontakt stellt die vertikale HIV-Transmission den häufigsten Infektionsmodus der kindlichen HIV-Infektion dar. Bei der vertikalen Transmission handelt es sich meist um eine prä- bzw. perinatale Infektion, wesentlich seltener ist eine postpartale Übertragung durch das Stillen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Belman AL, Diamond G, Dickson D (1988) Pediatric acquired immune deficiency syndrome: neurologic syndromes. Am J Dis Child 142: 29–35PubMedGoogle Scholar
  2. Belohradsky BH, Nißl L (1992) Impfungen bei sekundären Immundefekten — Indikationen, Impferfolge und Komplikationen. In: Ergebnisse der Inneren Medizin und Kinderheilkunde, Bd 60. Springer, Berlin Heidelberg New York Tokyo, S 241–331Google Scholar
  3. Bertolli J, St. Louis ME, Simonds RJ et al. (1996) Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasa, Zaire. J Infect Dis 174: 722–726PubMedCrossRefGoogle Scholar
  4. Blumberg BM, Gelbard HA, Epstein LG (1994) HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res 32: 253–267PubMedCrossRefGoogle Scholar
  5. Brouwers P, Moss H, Wolters P, Eddy J, Balis F, Poplack DG, Pizzo PA (1990) Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 117:980–985PubMedCrossRefGoogle Scholar
  6. Brouwers P, Belman AL, Epstein L (1994) Central nervous system involvement: manifestations, evaluation, and pathogenesis. In: Pizzo PA, Wilfert CM (eds) Pediatric AIDS, 2nd edn. Williams 8c Wilkins, Baltimore, pp 433–455Google Scholar
  7. Bulter KM, Husson RN, Lewis LL, Mueller BU, Benzon D, Pizzo PA (1992) CD 4 status and p24 antigenemia. Are they useful predictors of survival in HIV-infec-ted children receiving antiretroviral therapy? Am J Dis Child 146: 932–936Google Scholar
  8. Bye NR, Bernstein LJ, Glaser J, Kleid D (1990) Pneumocystis carinii pneumonia in young children with AIDS. Pediatr Pulmonol 9: 251–253PubMedCrossRefGoogle Scholar
  9. Calvelli TA, Rubinstein A (1986) Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis J 5: 207–210CrossRefGoogle Scholar
  10. CDC: Centers for Disease Control (1994 a) Zidovudine for the prevention of HIV transmission from mother to infant. MMWR 43: 285–287Google Scholar
  11. CDC (1994 b) Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43(RR-12): 1–19Google Scholar
  12. CDC (1995 a) Revised guidelines for prophylaxis against pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 44(RR-4): 1–11Google Scholar
  13. CDC (1995 b) USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 44(RR-8): 1–34Google Scholar
  14. CDC (1996) Update: Vaccine side effects, adverse reactions, contraindications and precautions. MMWR 45(RR-12): 1–35Google Scholar
  15. CDC (1997) USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 46(RR-12): 1–48Google Scholar
  16. Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: 483–489PubMedCrossRefGoogle Scholar
  17. Connor EM, Sperling RS, Gelber R et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331: 1173–1180PubMedCrossRefGoogle Scholar
  18. Consensus Statement (1996) Antiretroviral therapy for HIV infection in 1996. Recommendation of an international panel. JAMA 276: 146–154CrossRefGoogle Scholar
  19. DeCarli C, Civitello LA, Brouwers P, Pizzo PA (1993) The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol 34: 198–205PubMedCrossRefGoogle Scholar
  20. Dickover RE, Garratty EM, Herman SA et al. (1996) Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275: 599–605PubMedCrossRefGoogle Scholar
  21. Dunn DT, Brandt CD, Krivine A et al. (1988) Ribosomal RNA sequence shows pneu-mocystis carinii to be a member of the fungi. Nature 334: 519CrossRefGoogle Scholar
  22. Dunn DT, Brandt CD, Krivine A et. al. (1995) The sensivity of HIV-1 DNA polyme-rase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 9: F7–F11PubMedCrossRefGoogle Scholar
  23. ECS: European Collaborative Study (1990) Neurologic signs in young children with human immunodeficiency virus infection. Pediatr Infect Dis J 9: 402–406CrossRefGoogle Scholar
  24. ECS (1991) Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337: 253–260CrossRefGoogle Scholar
  25. ECS (1992) Risk factors for mother-to-child transmission of HIV-1. Lancet 339: 1007–1012CrossRefGoogle Scholar
  26. ECS (1994 a) Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343: 1464–1467CrossRefGoogle Scholar
  27. ECS (1994 b) Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 94: 815–819Google Scholar
  28. ECS (1994 c) Perinatal findings in children born to HIV-infected mothers. Br J Obstet Gyn 101: 136–141CrossRefGoogle Scholar
  29. ECS (1996) Characteristics of pregnant HIV-1 infected women in Europe. AIDS Care 8: 33–42CrossRefGoogle Scholar
  30. Edman JC, Kovacs JA, Masur H et al. (1988) Ribosomal RNA sequence shows pneu-mocystis carinii to be a member of the fungi. Nature 334: 519–522PubMedCrossRefGoogle Scholar
  31. El-Sadr W, Oleske JM, Agins BD (1994) Managing early HIV infection. Agency for health care policy and research. Clin Pract Guidel Ref Guide Clin 7: 1–37Google Scholar
  32. Epstein LG, Sharer LR, Oleske JM (1986) Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78: 678–687PubMedGoogle Scholar
  33. Farley J, Vink P (1996) Pediatric antiretroviral therapy: from research to practice. Ped AIDS HIV Infect 7: 9–13Google Scholar
  34. Fowler mg (1994) Pediatric HIV infection: neurologic and neuropsychologic findings. Acta Paediatr 400: 59–62CrossRefGoogle Scholar
  35. Gleason-Morgan D, Church JA, Ross LA (1994) A comparative study of transfusion-acquired human immunodeficiency virus-infected children with and without disseminated Mycobacterium avium complex. Pediatr Infect Dis J 13: 484–488PubMedCrossRefGoogle Scholar
  36. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ (1991) High risk of infection with human immunodeficiency virus type 1 for first born, vaginally delivered twins. Lancet 338: 1471–1475PubMedGoogle Scholar
  37. Hammer S, Katzenstein D, Hughes M, Gundacker H, Hirsch M, Merigan T (1995) Nucleoside monotherapy (MT) vs. combination therapy (CT) in HIV infected adults: a randomized double-blind, placebo-controlled trial in persons with CD 4 cell counts 200-500/mm3. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 17–20 Sept 1995, Abstract LB 1Google Scholar
  38. Havlir DV, Dube MP, Sattler FR et al. (1996) Prophylaxis against disseminated mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 335: 392–398PubMedCrossRefGoogle Scholar
  39. Hernandez-Sampelayo T (1994) Fluconazole vs. ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 13: 340–344PubMedCrossRefGoogle Scholar
  40. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD 4 lymphocytes in HIV-1 infection. Nature 373: 123–126PubMedCrossRefGoogle Scholar
  41. Jackson HC, Colthrust D, Hancock V, Miarriott MS, Tuite MF (1991) No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis carinii. J Infect Dis 163: 675–677PubMedCrossRefGoogle Scholar
  42. Lallemant M, Le Coeur S, Samba L, Cheynier D, M’Pele P, Nzingoula S, Esses M (1994) Mother-to-child transmission of HIV-1 in Congo, Central Africa. AIDS 8: 1451–1456PubMedCrossRefGoogle Scholar
  43. Landesman SH, Kalish LA, Burns DN et al. (1996) Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 334: 1617–1623PubMedCrossRefGoogle Scholar
  44. Lewis LL (1994) Nontuberculous mycobacterial infections. In: Pizzo PA, Wilfert CM (eds) Pediatric AIDS, 2nd edn. Williams & Wilkins, Baltimore, pp 308–320Google Scholar
  45. Lewis LL, Butler KM, Jusson RN, Mueller BU, Fowler CL, Steinberg SM, Pizzo PA (1992) Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr 121: 677–683PubMedCrossRefGoogle Scholar
  46. Lobato MN, Caldwell MB, Ng P, Oxtoby MJ (1995) Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. J Pediatr 126: 710–715PubMedCrossRefGoogle Scholar
  47. Luft BJ, Remington JS (1988) Toxoplasmic encephalitis. J Infect Dis 157: 1–6PubMedCrossRefGoogle Scholar
  48. Marchisio P, Principi N, Sorella S, Sala E, Tornaghi R (1996) Etiology of acute otitis media in human immunodeficiency virus-infected children. Pediatr Infect Dis J 15:58–61PubMedCrossRefGoogle Scholar
  49. McKinney RE, Maha MA, Connor EM et al. (1991) A multicenter trial of oral zido-vudine in children with advanced human immunodeficiency virus disease. N Engl J Med 324: 1018–1025PubMedCrossRefGoogle Scholar
  50. McLaughlin GE, Virdee SS, Schleien CL, Holzman BH, Scott GB (1995) Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii related respiratory failure. J Pediatr 126: 821–824PubMedCrossRefGoogle Scholar
  51. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167–1170PubMedCrossRefGoogle Scholar
  52. Mitchell CD (1994) Toxoplasmosis. In: Pizzo PA, Wilfert CM (eds) Pediatric Aids, 2nd edn. Williams & Wilkins, Baltimore, pp 419–431Google Scholar
  53. Mofenson LM, Spector SA (1994) Passive immunization strategies for HIV-infected children. In: Pizzo PA, Wilfert CM (eds) Pediatric AIDS, 2nd edn. Williams & Wilkins, Baltimore, pp 841–858Google Scholar
  54. Mofenson LM, National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group (1991) Intravenous immunoglobu-lin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 325: 73–80Google Scholar
  55. National Institutes of Health (1990) University of California Expert Panel for corti-costeroids as adjunctive therapy for pneumocystis carinii. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323: 1500–1504CrossRefGoogle Scholar
  56. Newell ML, Peckham CS (1995) The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS 9: F 7–F 11Google Scholar
  57. Newell ML, Dunn D, DeMaria A et al. (1996) Detection of virus in vertically exposed HIV-antibody negative children. Lancet 347: 213–214PubMedCrossRefGoogle Scholar
  58. Nozyce M, Hoberman M, Arpadi S et al. (1994) A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children. AIDS 8: 635–639PubMedCrossRefGoogle Scholar
  59. O’Brien WA, Grovit-Ferbas K et al. (1995) Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86: 1082–1089PubMedGoogle Scholar
  60. Pagano G, Kennedy W, Weiler S, McKinney R, Brown N, Hughes W (1993) The safety and pharmacokinetics of atovaquone in immunocompromised children. IXth International Conference on AIDS, Berlin, June 6–11, 1993, PO-B10-1455Google Scholar
  61. Pierce M, Crampton S, Henry D et al. (1996) A randomized trial of clarithromycin as prophylaxis against disseminated mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 335: 384–391PubMedCrossRefGoogle Scholar
  62. Pixley FJ, Wakefield AE, Banerji S, Hopkins JM (1991) Mitochondrial gene sequences show fungal homology for Pneumocystis carinii. Mol Microbiol 5: 1347–1351PubMedCrossRefGoogle Scholar
  63. Schäfer APA, Koch MA, Grosch-Wörner I, Friedmann W, Dudenhausen JW (1994) Wehen, Geburtsmodus und maternofetale Transmission von HIV. Geburtsh Frauenheilkd 54: 617–622CrossRefGoogle Scholar
  64. Shafran SD, Singer J, Zarowny DP et al. (1996) A comparison of two regimens for the treatment of mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin vs. rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 335: 377–383PubMedCrossRefGoogle Scholar
  65. Sleasman JW, Hemenway C, Klein AS, Barrett DJ (1993) Corticosteroids improve survival of children with AIDS and pneumocystis carinii pneumonia. Am J Dis Child 147: 30–34PubMedGoogle Scholar
  66. Spencer CM, Goa KL (1995) Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs 50/1: 176–196CrossRefGoogle Scholar
  67. Sperling RS, Shapiro DE, Coombs RW et al. (1996) Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 335: 1621–1629PubMedCrossRefGoogle Scholar
  68. STIKO (1996) Impfempfehlungen der Ständigen Impfkommission am Robert-Koch-Institut des Bundesgesundheitsamtes (STIKO); Stand: April 1996Google Scholar
  69. Tornatore C, Chandra R, Berger JR, Major EO (1994) HIV-1 infection of subcortical astrocytes in the Pediatric central nervous system. Neurology 44: 481–487PubMedGoogle Scholar
  70. Vigliano P, Rigardetto R, Capizzi G et al. (1994) EEG diagnostic and predictive value on HIV infection in childhood. Neurophysiol Clin 24: 367–79PubMedCrossRefGoogle Scholar
  71. Volberding PA (1996) HIV quantification: clinical applications. Lancet 347: 71–72PubMedCrossRefGoogle Scholar
  72. Wahn V, Belohradsky BH, Enenkel-Stood S et al. (1993) Behandlung von Sekundärinfektionen bei symptomatischer HIV-Infektion im Kindesalter. Monatsschr Kinderheilkd 141: 178–200PubMedGoogle Scholar
  73. Ward C, Salvato P, Thompson C (1996) HIV RNA changes in HIV positive patients following influenza vaccination. XI International Conference on AIDS, Vancouver July 7–12 (We.B.114)Google Scholar
  74. WHO-EC Collaborating Centre on AIDS. (1996) HIV/Aids Surveillance in Europe. Report no. 50Google Scholar
  75. Wong HR, Chundu KR (1994) Improved outcome for young children with Aids, Pneumocystis carinii pneumonia, and acute respiratory failure. Pediatr Pulmonol 18: 114–118PubMedCrossRefGoogle Scholar
  76. Zoubek A, Emminger W, Emminger-Schmidmeier W, Peters C, Pracher E, Grois N, Gadner H (1992) Conventional vs. liposomal Amphotericin B in immunossup-pressed children. Pediatr Hematol Oncol 19: 187–190CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • K. Seel
  • C. Feiterna-Sperling
  • I. Grosch-Wörner

There are no affiliations available

Personalised recommendations